pHAGE-PIK3CA Citations (2)

Originally described in: Systematic Functional Annotation of Somatic Mutations in Cancer.
Ng PK, Li J, Jeong KJ, Shao S, Chen H, Tsang YH, Sengupta S, Wang Z, Bhavana VH, Tran R, Soewito S, Minussi DC, Moreno D, Kong K, Dogruluk T, Lu H, Gao J, Tokheim C, Zhou DC, Johnson AM, Zeng J, Ip CKM, Ju Z, Wester M, Yu S, Li Y, Vellano CP, Schultz N, Karchin R, Ding L, Lu Y, Cheung LWT, Chen K, Shaw KR, Meric-Bernstam F, Scott KL, Yi S, Sahni N, Liang H, Mills GB Cancer Cell. 2018 Mar 12;33(3):450-462.e10. doi: 10.1016/j.ccell.2018.01.021. PubMed Journal

---

Articles Citing pHAGE-PIK3CA

Articles
PIK3CA hotspot mutations p. H1047R and p. H1047L sensitize breast cancer cells to thymoquinone treatment by regulating the PI3K/Akt1 pathway. Zhou J, Imani S, Shasaltaneh MD, Liu S, Lu T, Fu J. Mol Biol Rep. 2022 Mar;49(3):1799-1816. doi: 10.1007/s11033-021-06990-x. Epub 2021 Nov 23. PubMed
ErbB signaling is a potential therapeutic target for vascular lesions with fibrous component. Jauhiainen S, Ilmonen H, Vuola P, Rasinkangas H, Pulkkinen HH, Keranen S, Kiema M, Liikkanen JJ, Laham-Karam N, Laidinen S, Beter M, Aavik E, Lappalainen K, Lohi J, Aronniemi J, Ord T, Kaikkonen MU, Salminen P, Tukiainen E, Yla-Herttuala S, Laakkonen JP. Elife. 2023 May 18;12:e82543. doi: 10.7554/eLife.82543. PubMed

If you have published an article using this material, please email us at to have your article added to this page.